Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT03627988

Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. — MARTA  

Breast Cancer Invasive Clinical Trial

Official title:
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.

Clinical Trial Summary

Prospective, multicentric, non-randomized phase II study evaluating the surgical treatment by mastectomy with immediate prosthetic breast reconstruction in patients with breast cancer and receiving adjuvant therapy by TomoTherapy +/-Chemotherapy. Patients with non-inflammatory and non-metastatic invasive mammary carcinoma will be included in this study. The study procedure will be a surgical treatment by mastectomy with immediate prosthetic breast reconstruction followed by an adjuvant therapy: TomoTherapy +/-Chemotherapy (radiation therapy alone or preceded by chemotherapy). The nature of the chemotherapy treatment will be decided according to the standards of each center. The patients will be followed for the study up to 36 months after the surgical procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03627988
Study type Interventional
Source Institut Claudius Regaud
Contact
Status Active, not recruiting
Phase Phase 2
Start date June 7, 2019
Completion date May 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03664895 - Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial) Phase 3
Recruiting NCT05505357 - Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) N/A
Completed NCT03669705 - No Axillary Surgery for Early Breast Cancer.
Terminated NCT05012397 - Milademetan in Advanced/Metastatic Solid Tumors Phase 2
Recruiting NCT05877859 - Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Active, not recruiting NCT04398914 - Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Recruiting NCT05351424 - AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc N/A
Completed NCT05300412 - The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer
Recruiting NCT04999917 - Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer N/A
Recruiting NCT05910398 - Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer Phase 3
Completed NCT05019989 - Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study N/A
Recruiting NCT06144944 - Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer Phase 3
Recruiting NCT04891068 - BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer Phase 2
Recruiting NCT05939310 - Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study N/A
Recruiting NCT06401304 - Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
Not yet recruiting NCT06268665 - Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Phase 2
Completed NCT05463276 - The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Completed NCT04729647 - Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer N/A
Active, not recruiting NCT06234488 - Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Recruiting NCT00437879 - Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.